Efficient ex vivo expansion of NOD/SCID-repopulating cells with lympho-myeloid potential in hematopoietic grafts of children with solid tumors

Hematology Journal

Volumn 2, Issue 2, 2001, Pages 108-116

  Tourino, C ^a   Pflumio, F ^a   Novault, S ^a   Masse A ^a   Guiller, M ^a   Bonnet, M L ^a   Valteau Couanet, D ^a   Hartmann, O ^a   Vainchenker, W ^a   Beaujean, F ^a   Coulombel, L ^a   Turhan, A G ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Autograft; LTC IC; NOD SCID RC expansion

Indexed keywords

CD15 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 3; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; STEM CELL FACTOR;

ARTICLE; ASSAY; BONE MARROW; BONE MARROW CELL; CANCER CHEMOTHERAPY; CASE REPORT; CELL COUNT; CELL CULTURE; CELL FRACTIONATION; CELL NUCLEUS; CHILD; CLINICAL PROTOCOL; COLONY FORMING CELL; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MEGADOSE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; POPULATION DYNAMICS; SCID MOUSE; SERUM; SOLID TUMOR; UMBILICAL CORD BLOOD;

ANIMALS; CHILD, PRESCHOOL; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; LYMPHOPOIESIS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MYELOPOIESIS; NEOPLASMS;

EID: 0035004689     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200083     Document Type: Article

References (28)

1. The biology and clinical uses of blood stem cells
2. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma Intergroupe Francias du Myelome
4. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor
5. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma
6. + cells enriched from human bone marrow
7. + cells into the myeloid lineage
8. + progenitor cells by stem cell factor, interleukin-1 b (IL-1b), IL-6, IL-3, Interferon gamma, and erythropoietin
9. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo
10. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells
11. Ex-vivo expansion of hematopoetic progenitor cells: Preliminary results in breast cancer
12. CD34 positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity
13. Murine long-term repopulating ability is compromised by ex vivo culture in serum free medium despite preservation of committed progenitors
14. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells resulted in diminished long-term repopulating ability
15. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens
16. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy
17. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
18. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture
19. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lymphomyeloid repopulating activity in nonobese diabetic-scid/scid mice
20. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
21. Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34+ +/CD38- long-term culture-initiating cells
22. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of mononuclear cells
23. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics
24. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells afer ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells
25. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+ Thy-1 + Lin-primitive progenitor cells
26. Differential cytokine effects on primitive (CD34 + CD38-) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoietin
27. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3
28. Thrombopoietin, steel factor and the ligand for flt3/flk2 interact to stimulate the proliferation of human hematopoietic progenitors in culture